- Home
- WSFS vs DYN Comparison
WSFS vs DYN Comparison
Compare WSFS & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSFS | DYN |
|---|---|---|
| Founded | 1980 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.0B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WSFS | DYN |
|---|---|---|
| Price | $71.87 | $17.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 14 |
| Target Price | ★ $76.20 | $37.00 |
| AVG Volume (30 Days) | 320.1K | ★ 1.7M |
| Earning Date | 04-23-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | ★ 15.42 | N/A |
| EPS | ★ 5.09 | N/A |
| Revenue | ★ $963,949,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.40 | N/A |
| P/E Ratio | $14.01 | ★ N/A |
| Revenue Growth | ★ 50.18 | N/A |
| 52 Week Low | $49.92 | $8.25 |
| 52 Week High | $73.06 | $25.00 |
Technical Indicators
Market Signals| Indicator | WSFS | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 65.52 | 44.70 |
| Support Level | $53.40 | $16.47 |
| Resistance Level | N/A | $19.65 |
| Average True Range (ATR) | 1.46 | 0.99 |
| MACD | 0.09 | -0.28 |
| Stochastic Oscillator | 78.10 | 12.32 |
Price Performance
Historical ComparisonAbout WSFS WSFS Financial Corporation
WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: WSFS Bank provides loans and leases and other financial products to commercial and consumer customers. Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and Wealth Management provides a broad array of planning and advisor services, investment management, personal and institutional trust services, and credit and deposit products to individuals, corporate, and institutional clients. Majority revenue is generated from WSFS Bank segment.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.